175 YoonH
Successfully navigating colonoscopy prep with GLP-1 patients requires a multifaceted approach that addresses both the pharmacologic challenges and patient education gaps
mTOR is induced by Flt3 ligand (Flt3L) and is necessary for the Flt3L-driven development of DCs [100], and mTOR inhibits IL-1 production to impede DC maturation and the ability to stimulate effector T cell responses
How Biomarkers & Genetics Can Inform Your Treatment Strategy Genetic variations in GLP-1 receptor pathways (GLP1R rs6923761), GIPR signaling (GIPR rs1800437), and appetite-control genes (FTO rs9939609, MC4R rs17782313) may provide context for how your body responds to GLP-1 therapies
Factors that influence dosing speed include your starting body mass, metabolic rate, concurrent medications, and previous weight loss medication experience
Everyone focuses on eating enough and taking supplements, which is important